SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ILLUMINA
(NQNM:ILMN Last Sale: 308.2 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ILMN : $308.2)
$45,248,158 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
9390 Towne Centre Drive Research Report Earnings Snapshot - Last 01/27/19
Suite 200 Fact Sheet
San Diego, CA 92121 Financial Statements
Phone: (858) 202-4500 Peer Comparison
Annual Reports

Jay T. Flatley, Pres./CEO, John R. Stuelpnagel, COO, Christian Henry, CFO
Developing instruments that measure genetic variation to develop new treatment for diseases. IPO at $16 July 27, 2000. Raised $96 million, selling 6 million shares, 19% of the outstanding. Lead Manager: Goldman Sachs. Secondary sold 3.5 million shares at $25.50 May 19, 2006, raising $83.6 million. Acquired SOLEXA INC (Q:SLXA) January 26, 2007 for 12.5 million shares, issuing 0.344 ILMN per SLXA.
Historical Charts    Technical Analysis
No Historical Data available for ILMN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ILMN $308.2 $308.2 0 .0 $304.09 $309.42 608,568 $304.09 $309.42 146,814,271
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
22-SEP-08 ILMN Split 2 for 1

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex